Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Virology|March 16, 2018
Domains of the Hepatitis B Virus Small Surface Protein S Mediating OligomerizationSascha Suffner, Nadine Gerstenberg, Maria Patra, et al.
Frontiers in Immunology|November 6, 2023
Preclinical study of CD19 detection methods post tafasitamab treatmentKristina Ilieva, Markus Eberl, Jan Jaehrling, et al.
Science (New York, N.Y.)|December 5, 2015
Cytoplasmic protein aggregates interfere with nucleocytoplasmic transport of protein and RNAAndreas C Woerner, Frédéric Frottin, Daniel Hornburg, et al.
Cancer Immunology, Immunotherapy : CII|March 29, 2022
Tafasitamab mediates killing of B-cell non-Hodgkin's lymphoma in combination with γδ T cell or allogeneic NK cell therapyJung Hyun Her, Dominik Pretscher, Maria Patra-Kneuer, et al.
Molecular Cell|March 5, 2013
The E3 ligase parkin maintains mitochondrial integrity by increasing linear ubiquitination of NEMOAnne Kathrin Müller-Rischart, Anna Pilsl, Patrick Beaudette, et al.
Frontiers in Immunology|August 21, 2023
Activity of tafasitamab in combination with rituximab in subtypes of aggressive lymphomaMaria Patra-Kneuer, Gaomei Chang, Wendan Xu, et al.
Haematologica|June 27, 2024
Blockade of the CD47/SIRPα checkpoint axis potentiates the macrophage-mediated antitumor efficacy of tafasitamabAlexander Biedermann, Maria Patra-Kneuer, Dimitrios Mougiakakos, et al.
The EMBO Journal|March 20, 2019
A protein quality control pathway regulated by linear ubiquitinationEva M van Well, Verian Bader, Maria Patra, et al.
Blood|October 25, 2023
CD19 occupancy with tafasitamab increases therapeutic index of CART19 cell therapy and diminishes severity of CRSR Leo Sakemura, Claudia Manriquez Roman, Paulina Horvei, et al.
Pageof 1